mRNA |
Cyclopamine |
FIMM |
pan-cancer |
AAC |
-0.071 |
0.6 |
mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.6 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
GDC-0449 |
FIMM |
pan-cancer |
AAC |
-0.083 |
0.6 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.6 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |